J E Liljenquist

3.0k total citations · 1 hit paper
44 papers, 2.5k citations indexed

About

J E Liljenquist is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, J E Liljenquist has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in J E Liljenquist's work include Metabolism, Diabetes, and Cancer (19 papers), Diabetes Management and Research (15 papers) and Diabetes Treatment and Management (12 papers). J E Liljenquist is often cited by papers focused on Metabolism, Diabetes, and Cancer (19 papers), Diabetes Management and Research (15 papers) and Diabetes Treatment and Management (12 papers). J E Liljenquist collaborates with scholars based in United States and Australia. J E Liljenquist's co-authors include W. W. Lacy, Alan D. Cherrington, Ulrich Keller, J L Chiasson, B. C. SINCLAIR-SMITH, Paul A. Insel, Jordan D. Tobin, Robert S. Sherwin, Mones Berman and Reubin Andres and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

J E Liljenquist

43 papers receiving 2.2k citations

Hit Papers

A Model of the Kinetics of Insulin in Man 1974 2026 1991 2008 1974 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J E Liljenquist United States 26 1.4k 1.0k 996 837 330 44 2.5k
Yolanta T. Kruszynska United Kingdom 25 760 0.5× 1.1k 1.1× 430 0.4× 858 1.0× 987 3.0× 55 2.5k
Søren A. Urhammer Denmark 32 810 0.6× 930 0.9× 829 0.8× 1.2k 1.4× 428 1.3× 50 2.6k
Roger L. Lerner United States 14 910 0.6× 438 0.4× 610 0.6× 396 0.5× 180 0.5× 18 1.4k
Lidia Maianu United States 15 357 0.3× 670 0.6× 507 0.5× 1.0k 1.2× 188 0.6× 23 1.8k
Moritake Higa Japan 19 606 0.4× 1.2k 1.2× 704 0.7× 1.1k 1.3× 735 2.2× 37 3.0k
Ariel Zisman United States 10 743 0.5× 485 0.5× 375 0.4× 732 0.9× 170 0.5× 14 1.6k
Eric D. Hawkins United States 11 341 0.2× 893 0.9× 473 0.5× 2.2k 2.6× 580 1.8× 17 3.1k
Naoki Kumashiro Japan 19 1.1k 0.8× 732 0.7× 438 0.4× 631 0.8× 1.0k 3.1× 43 2.2k
Asger Lund Denmark 24 1.8k 1.2× 455 0.4× 1.1k 1.1× 923 1.1× 337 1.0× 79 2.6k
Takamasa Higashimori United States 13 288 0.2× 1.3k 1.3× 348 0.3× 1.1k 1.4× 766 2.3× 15 2.3k

Countries citing papers authored by J E Liljenquist

Since Specialization
Citations

This map shows the geographic impact of J E Liljenquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J E Liljenquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J E Liljenquist more than expected).

Fields of papers citing papers by J E Liljenquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J E Liljenquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J E Liljenquist. The network helps show where J E Liljenquist may publish in the future.

Co-authorship network of co-authors of J E Liljenquist

This figure shows the co-authorship network connecting the top 25 collaborators of J E Liljenquist. A scholar is included among the top collaborators of J E Liljenquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J E Liljenquist. J E Liljenquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krell, Kenneth, et al.. (2001). Temporary Reversal by Topotecan of Marked Insulin Resistance in a Patient With Myelodysplastic Syndrome. American Journal of Clinical Oncology. 24(3). 279–282.
2.
Drexler, Andrew, et al.. (1995). Patient-reported experience with velosulin® Human insulin in continuous subcutaneous insulin infusion. Clinical Therapeutics. 17(2). 204–213. 1 indexed citations
3.
Connis, Richard T., Thomas R. Taylor, Michael J. Gordon, et al.. (1989). Changes in cognitive and social functioning of diabetic patients following initiation of insulin infusion therapy. Experimental Aging Research. 15(2). 51–60. 11 indexed citations
4.
Cherrington, Alan D., et al.. (1982). Insulin as a mediator of hepatic glucose uptake in the conscious dog. American Journal of Physiology-Endocrinology and Metabolism. 242(2). E97–E101. 51 indexed citations
5.
Stacpoole, Peter W., Jonathan B. Jaspan, A. G. Kasselberg, et al.. (1981). A familial glucagonoma syndrome. The American Journal of Medicine. 70(5). 1017–1026. 32 indexed citations
6.
Liljenquist, J E, et al.. (1981). Retardant Effect of Hyperglycemia on the Rise in Plasma Fatty Acids Following Insulin Withdrawal in Man. Hormone and Metabolic Research. 13(10). 542–545. 5 indexed citations
7.
Sundell, Håkan, et al.. (1980). Treatment of intractable neonatal hypoglycemia with somatostatin plus glucagon. The Journal of Pediatrics. 96(1). 148–151. 20 indexed citations
8.
Shulman, Gerald I., Phillip E. Williams, J E Liljenquist, et al.. (1980). Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog. Metabolism. 29(4). 317–320. 48 indexed citations
9.
Liljenquist, J E, G. Mueller, Alan D. Cherrington, James Perry, & D. Rabinowitz. (1979). HYPERGLYCEMIA PER SE (INSULIN AND GLUCAGON WITHDRAWN) CAN INHIBIT HEPATIC GLUCOSE PRODUCTION IN MAN. The Journal of Clinical Endocrinology & Metabolism. 48(1). 171–175. 88 indexed citations
10.
Rabin, David, G. Mueller, W. W. Lacy, & J E Liljenquist. (1979). Splanchnic Metabolism of Alanine in Intact Man: Effects of Somatostatin and Somatostatin Plus Insulin. Diabetes. 28(5). 486–490. 7 indexed citations
11.
Cherrington, Alan D., et al.. (1978). Control of hepatic glucose output by glucagon and insulin in the intact dog.. PubMed. 31–45. 31 indexed citations
12.
Chiasson, J L, Richard L. Atkinson, Alan D. Cherrington, et al.. (1978). Effects of Fasting on Gluconeogenesis from Alanine in Nondiabetic Man. Diabetes. 28(1). 56–60. 27 indexed citations
13.
Jennings, Anthony S., Alan D. Cherrington, J E Liljenquist, et al.. (1977). The Roles of Insulin and Glucagon in the Regulation of Gluconeogenesis in the Postabsorptive Dog. Diabetes. 26(9). 847–856. 31 indexed citations
14.
Cherrington, Alan D., J L Chiasson, J E Liljenquist, et al.. (1976). The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.. Journal of Clinical Investigation. 58(6). 1407–1418. 217 indexed citations
15.
Liljenquist, J E, J L Chiasson, Alan D. Cherrington, et al.. (1976). An important role for glucagon in the regulation of glucose production in vivo. Metabolism. 25(11). 1371–1373. 8 indexed citations
16.
Chiasson, J L, et al.. (1976). Differential sensitivity of glycogenolysis and gluconeogenesis to insulin infusions in dogs. Diabetes. 25(4). 283–291. 39 indexed citations
17.
Insel, Paul A., J E Liljenquist, Jordan D. Tobin, et al.. (1975). Insulin Control of Glucose Metabolism in Man. Journal of Clinical Investigation. 55(5). 1057–1066. 196 indexed citations
18.
Chiasson, J L, J E Liljenquist, B. C. SINCLAIR-SMITH, & W. W. Lacy. (1975). Gluconeogenesis from alanine in normal postabsorptive man. Intrahepatic stimulatory effect of glucagon. Diabetes. 24(6). 574–584. 46 indexed citations
19.
Insel, P A, Karl J. Kramer, R S Sherwin, et al.. (1974). Modeling the insulin-glucose system in man.. PubMed. 33(7). 1865–8. 13 indexed citations
20.
Sherwin, Robert S., Karl J. Kramer, Jordan D. Tobin, et al.. (1974). A Model of the Kinetics of Insulin in Man. Journal of Clinical Investigation. 53(5). 1481–1492. 386 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026